A 55-year-old man with a radiation-induced esophageal stricture experienced an esophagopleural fistula (EPF) as an adverse event of endoscopic balloon dilation therapy. Despite 9 months of covered esophageal stent treatment, the fistula persisted (Figs. 1A and B) . Owing to its recessed position and fibrotic nature, endoclip closure was unlikely to be beneficial (Fig. 1C) . The patient underwent an Eloesser flap thoracostomy, and 2 months later, an atrial septal occluder was deployed ( Fig. 1D ; Video 1, available online at www.VideoGIE.org). The cavernostomy wound was unpacked. Under endoscopic guidance, an atrial septal occluder device was passed through the fistula and into the esophagus (Fig. 1E) . The proximal end of the occluder was deployed and pulled against the esophageal wall. The distal end was then deployed in a standard fashion (Fig. 1F) . Once the occluder was deployed, the distal end was sutured to the chest wall in 2 locations with 4-0 Polysorb suture (Polysor, Covidien, Medtronic, Minneapolis, Minn), to ensure anchoring and prevent disruption with dressing changes (Fig. 1G ). An initial esophagogram performed 1 week after deployment showed a persistent leak, but time was allowed to achieve tissue ingrowth of the device, and at 4 weeks, closure of the fistula was confirmed (Figs. 1H and I ). An atrial septal occluder device should be considered for persistent EPFs that fail conventional therapy.
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